Related Experiment Video
Updated: Jul 11, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Partners in diabetes epidemic: A global perspective
Huan Wang1,2, Safoura Akbari-Alavijeh3,4, Ranjit S Parhar5
1College of Bioscience and Biotechnology, Shenyang Agricultural University, Shenyang 110866, Liaoning Province, China.
This review highlights key factors in diabetes development, including insulin signaling, genetics, and the gut microbiome. Further research and collaboration are crucial for effective diabetes management and control.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Microbiology
Background:
- Global rise in obesity and diabetes necessitates understanding complex disease mechanisms.
- Diabetes involves intricate physiological dysfunctions including insulin resistance, genetic predispositions, and environmental factors.
Purpose of the Study:
- To review major determinants of diabetes, focusing on insulin signaling, genetics, environment, lipid metabolism, and mitochondria.
- To explore the role and mechanisms of gut microbiota in the pathogenesis of diabetes.
Main Methods:
- Comprehensive literature search across major databases (PubMed, MEDLINE, EMBASE, Google Scholar, Cochrane).
- Inclusion of 144 full-length articles encompassing laboratory experiments, epidemiological data, clinical trials, and meta-analyses.
- Assessment of diverse evidence including experimental models and review articles.
Main Results:
- Identified insulin signaling, genetics, environment, obesity, lipid metabolism, and mitochondria as critical factors in diabetes.
- Highlighted emerging evidence implicating gut microbiome as a significant regulator in diabetes development.
- Discussed challenges and the need for further research in diabetes etiology.
Conclusions:
- Diabetes is a complex metabolic disorder influenced by multiple interconnected factors.
- The gut microbiome presents a promising area for future therapeutic strategies in diabetes.
- Emphasized the need for collaborative research between academia and industry for accelerated progress in diabetes control.
More Related Videos
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
08:16Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
Published on: March 15, 2024
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Oral Hypoglycemic Agents: Biguanides and Glitazones